Results 271 to 280 of about 288,867 (293)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

Nature Reviews Clinical Oncology, 2022
Annika Schaefer, Bernhard Woermann, Corine H Geurtsvankessel   +2 more
exaly  

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Lancet, The, 2021
Olivier J Wouters, Kenneth C Shadlen, Maximilian Salcher-Konrad   +2 more
exaly  

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

Lancet, The, 2021
Rajeka Lazarus, Heike Cappel-Porter, Andrew Carson-Stevens   +2 more
exaly  

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Lancet, The, 2021
Alasdair P S Munro, Victoria R Cornelius, Parvinder Aley   +2 more
exaly  

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Lancet, The, 2022
Daniel R Feikin, Laith Abu-Raddad, Rafael Araos   +2 more
exaly  

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

Nature Reviews Immunology, 2021
John S Tregoning, Katie Elizabeth Flight, Ziyin Wang   +2 more
exaly  

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Nature Reviews Drug Discovery, 2021
Namit Chaudhary, Drew Weissman, Kathryn A Whitehead   +2 more
exaly  

Viral targets for vaccines against COVID-19

Nature Reviews Immunology, 2020
Lianpan Dai, George F Gao
exaly  

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021
James A Lopez Bernal, Nick Andrews, Ruth Simmons   +2 more
exaly  

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

New England Journal of Medicine, 2022
Nick Andrews, Elise Tessier, Julia Stowe
exaly